Nuvation Bio Inc.
NUVB
$8.11
$0.648.50%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.12M | 4.83M | 3.08M | 5.71M | 727.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.12M | 4.83M | 3.08M | 5.71M | 727.00K |
| Cost of Revenue | 3.35M | 2.58M | 2.09M | 4.22M | 1.52M |
| Gross Profit | 9.77M | 2.26M | 990.00K | 1.50M | -788.00K |
| SG&A Expenses | 37.36M | 38.48M | 35.39M | 26.14M | 19.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.55M | 68.42M | 62.09M | 59.65M | 48.83M |
| Operating Income | -56.43M | -63.59M | -59.00M | -53.94M | -48.10M |
| Income Before Tax | -55.79M | -59.01M | -53.24M | -49.45M | -41.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -55.79M | -59.01M | -53.24M | -49.45M | -41.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.79M | -59.01M | -53.24M | -49.45M | -41.21M |
| EBIT | -56.43M | -63.59M | -59.00M | -53.94M | -48.10M |
| EBITDA | -55.90M | -63.23M | -58.69M | -53.72M | -47.94M |
| EPS Basic | -0.16 | -0.17 | -0.16 | -0.15 | -0.15 |
| Normalized Basic EPS | -0.10 | -0.11 | -0.10 | -0.09 | -0.09 |
| EPS Diluted | -0.16 | -0.17 | -0.16 | -0.15 | -0.15 |
| Normalized Diluted EPS | -0.10 | -0.11 | -0.10 | -0.09 | -0.09 |
| Average Basic Shares Outstanding | 342.39M | 340.75M | 338.61M | 336.93M | 273.57M |
| Average Diluted Shares Outstanding | 342.39M | 340.75M | 338.61M | 336.93M | 273.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |